United States: Digital Health Law Update Vol. 1 Issue 4

Industry Insights

Are You Ready for Digital-Health Patent Disputes? Getting Strong Patents and Challenging Weak Ones in the Evolving Minefield of U.S. Patent Law

by Doug Pearson, Greg Castanias, Mark Paulson, and Vishal Khatri

With exponential growth occurring in the availability of telemedicine and other digital health products and services, patent disputes are sure to erupt. A recent example is the patent suit filed by American Well, a telemedicine provider, against Teladoc in June 2015, alleging infringement of American Well's patent by Teladoc's telehealth services. The suit was initiated after Teledoc filed an inter partes review ("IPR") petition with the U.S. Patent and Trademark Office ("USPTO") to challenge the validity of the American Well patent in March 2015. In pursuing the IPR proceeding, Teladoc is making use of changes to the U.S. patent law made possible by the America Invents Act, which became effective in 2012.

With the ability to challenge the validity of patents in both federal courts and the USPTO, the need for patent owners to acquire strong patents, and the need for challengers to understand likely areas of weakness, are more important than ever. The terrain is particularly treacherous for computer-implemented inventions (also called software inventions) in light of several recent court decisions addressing, among other things, the subject matter eligible for patenting (Alice Corporation Pty. Ltd. v. CLS Bank International, et al.), whether direct infringement must be attributable to a single entity (Akamai Techs., Inc. v. Limelight Networks, Inc.), and the effect on patent validity/scope of an unintended "means" interpretation (Williamson v. Citrix Online, LLC). While the challenges facing digital health patent holders can be significant given these recent court rulings, they can be overcome in many instances with an eye toward good claim drafting for new and pending patent applications and through possible use of the "reissue" process at the USPTO to correct patent claims before asserting the patent in litigation.

Abstract Ideas. In Alice Corporation Pty. Ltd. v. CLS Bank International, et al., the U.S. Supreme Court set out in June 2014 a two-part test for whether subject matter is eligible for patenting in the first place, which is different from the more commonly known hurdles of novelty and nonobviousness. The test has been applied with devastating effect by district courts and the USPTO to invalidate patents or reject patent claims on grounds that they claim no more than general computer implementations of abstract ideas. With little guidance from the upper courts on (i) what constitutes an "abstract idea" and (ii) what constitutes "significantly more" than the abstract idea under the two-part test, lower courts and the USPTO have struggled. As a practical matter, if the patent claims are not sufficiently technical and are not rooted in computer technology, and instead recite mere implementation of well-known concepts with a general-purpose computer, the claims are likely vulnerable under Alice. While this presents a challenge for those trying to get patent applications on software inventions granted by the USPTO, many issues can be overcome with careful claim drafting. Alice issues can be devastating, however, to patents that were granted before Alice and its recent predecessor cases, and these patents may be candidates for the "reissue" process at the USPTO to have patent claims corrected and reissued before assertion in litigation.

Divided Infringement. The Federal Circuit ruled in May 2015 in Akamai Techs., Inc. v. Limelight Networks, Inc. that direct infringement does not exist where the accused acts are not attributable to a single entity, i.e., are not carried by a single actor, or are not carried out by multiple actors in an agency relationship, contractual relationship, or joint venture. This ruling followed the Supreme Court's decision in June 2014 in Limelight Networks, Inc. v. Akamai Technologies, Inc., where the Supreme Court refused to find indirect patent infringement where there was no underlying direct patent infringement attributable to a single entity. In this case, Akamai had sued Limelight for induced infringement based on the aggregate activities of Limelight and its customers, and although it initially won at the district court and the Federal Circuit, it ultimately lost based on the two subsequent decisions noted above. The cases are important because they underscore the importance of drafting patent claims in a manner to be attributable to a single entity, which is certainly possible in digital health and telemedicine contexts where the inventions may involve the acts of multiple entities. Granted patents that may suffer from divided infringement issues may be candidates for reissue prior to assertion in litigation.

"Means" Interpretation. Under longstanding precedent, when a patent claim has recited in a claim element "means" for carrying out a particular function, there has been a rebuttable presumption that the claim element should be interpreted as a "means-plus-function" element, which by statute limits the scope of the element to the specific structure disclosed in the patent specification for carrying out the claimed function and to equivalents of the disclosed structure. Likewise, there has been a strong presumption that this statutory claim interpretation did not apply where the claim did not recite the word "means." In June 2015 in Williamson v. Citrix Online, LLC, the Federal Circuit overruled precedent regarding the latter and held that the standard is whether "the words of the claim are understood by persons of ordinary skill in the art to have a sufficiently definite meaning as the name for structure." Where a claim element is found to not satisfy the standard (because it recites primarily functional, as opposed to structural, subject matter), the statutory "means" construction applies even if the claim element does not use the word "means." This ruling could have significant impact for digital-health patents and applications where the claim elements are often recited in very functional terms (as opposed to structural terms). On one hand, it could result in certain claim elements being interpreted more narrowly than intended. On the other, it could result in some claims being held invalid as indefinite on grounds that the patent specification does not disclose sufficient structure for carrying out the claimed function. While potential issues may be remedied for patent applications that are pending, patents that have already been granted and that are believed to be vulnerable may be candidates for reissue.

For additional information, see other Jones Day Alerts and Commentaries:

Alice Corp. v. CLS Bank: Did the Supreme Court Sign the Warrant for the "Death of Hundreds of Thousands of Patents"?

Software Inventions—Keeping it Eligible

Divided Federal Circuit Panel Stands by the Single Entity Rule for Direct Patent Infringement

Federal Circuit Upends Presumption for Means-Plus-Function Claiming

Federal Features

21st Century Cures—On July 10, 2015, the U.S. House of Representatives passed H.R.6, the 21st Century Cures Act, focused on reducing regulatory obstacles associated with new pharmaceuticals and medical devices and other innovative therapies. The House bill was approved by a vote of 344–77, and although a companion bill is pending in the Senate, it has yet to advance beyond the committee level. The House action follows months of congressional hearings and negotiations among policymakers and related stakeholders, including with respect to digital health measures. The final bill addresses telehealth mostly in the abstract by requiring the Centers for Medicare & Medicaid Services ("CMS") and the Medicare Payment Advisory Committee (known as MedPac) to submit information to congressional committees regarding barriers to the expansion of telehealth services, results of Medicare telehealth pilot projects, and recommendations for diagnosis and treatment codes that should be covered by telehealth reimbursement. In June 2015, the American Telemedicine Association published recommendations in an effort to bolster the bill's telehealth provisions, including proposals to waive Medicare telehealth restrictions for Accountable Care Organizations ("ACOs") and to align CMS's policies for remote patient monitoring with recent developments in chronic care management services, but the final bill did not feature these provisions. Discussion of telehealth policies could resurface if the Senate considers counterpart legislation.

MSSP "Enabling Technologies"—In June 2015, CMS issued a final rule implementing changes to the Medicare Shared Savings Program ("MSSP"). The rule includes data sharing policies to help ACOs more easily access patient data and encourage greater coordination of care. Under the rule, "enabling technologies" may include electronic health records and other health IT tools; telehealth services, such as remote patient monitoring; electronic exchange of health information; and other electronic tools to engage beneficiaries in their care. The changes are effective November 1, 2015.

Telehealth Legislation—Congress has seen a recent flurry of other bills related to telehealth. Last month, Reps. Mike Thompson (D-CA) and Gregg Harper (R-MS) introduced H.R.2948, the Medicare Telehealth Parity Act of 2015, resurrecting prior proposals by Congress to put telehealth services on a path toward Medicare reimbursement parity with in-person health care. Also, a group led by Reps. Thompson and Morgan Griffith (R-VA) has introduced H.R.2799, the Furthering Access to Stroke Telemedicine (FAST) Act, aimed at expanding access to telestroke treatments. Companion legislation was introduced in the Senate in May 2015. Additionally, Sens. Mark Warner (D-VA), Johnny Isakson (R-GA), and others have proposed S.1549, which features proposals for coverage of 24-hour access emergency support via telemedicine or telephone as part of "advanced illness care coordination services."

EHR/EDC Integration Projects—In June 2015, the Food and Drug Administration ("FDA") announced plans for pilot projects aimed at integrating the often "siloed" data systems used in patient care and clinical research. Electronic health records ("EHRs") are the mainstay of health care practitioners, whereas clinical research for pharmaceutical products increasingly involves data collection and analysis through electronic data capture ("EDC") approaches. FDA's notice requests applications from stakeholders interested in participating in the pilot projects and general comments regarding the use of standards-based technology solutions for eliminating duplication in data capturing and transmission, as well as the facilitation of remote monitoring of data to reduce onsite visits. Applications and comments are due August 10, 2015.

State Summaries

Interstate Medical Licensure Compact—In July 2015, Illinois officially joined the Interstate Medical License Compact ("Compact"), becoming the 11th state to adopt the policy initiative that relaxes certain administrative requirements of licensure for physicians practicing medicine across state lines. Earlier this summer, Minnesota and Nevada adopted the Compact. Follow the status of these state bills and learn about the Compact at licenseportability.org.

Connecticut—On June 23, 2015, Connecticut's governor signed a new law, "Concerning the Facilitation of Telehealth." Effective October 1, 2015, each provider (including physicians and non-physician providers) furnishing services via telehealth to patients in Connecticut must meet certain requirements set out in the statute, including, among others, a specific patient consent, identification of the provider's license number and contact information, and access to the patient's medical record.

Delaware—On July 7, 2015, Delaware enacted a new statute regarding telemedicine services. Effective immediately, the legislation sets out several notable requirements for telemedicine providers, including disclosure of the provider's identity and credentials, patient consent, the provision of a written summary to the patient, and, where the standard of care requires, either an in-person examination or both an audio and visual communication prior to diagnosis and treatment. In contrast to many other similar recent state actions, the Delaware law allows for the prescription of controlled substances through telemedicine in certain circumstances.

Iowa—In June 2015, the Iowa Supreme Court invalidated a recent rule by the state's medical board that had required physicians to conduct in-person examinations prior to administering abortion-inducing drugs. In the opinion, the court held that the rule violates the state constitution by placing an "undue burden" on women located in remote areas, and it also noted that the state already allows telemedicine in other situations.

Maine—In June 2015, the governor of Maine signed a new law allowing the state medical board to register out-of-state licensed physicians to provide medical services via interstate telemedicine to patients located in Maine, if certain requirements are met. The law goes into effect September 15, 2015.

New Hampshire—Effective September 11, 2015, providers delivering telemedicine services in New Hampshire will need to comply with a statute signed into law last month. In particular, the new statute specifies that prescribing without a physician–patient relationship is unprofessional conduct subject to discipline (noting that a physician–patient relationship can be established by either in-person or face-to-face, real-time communication). The statute also limits the prescribing of certain controlled substances based solely on a telemedicine examination.

Reimbursement Review

State Reimbursement—Legislatures in the following states approved telehealth reimbursement measures: Connecticut, Delaware, New Hampshire, Oregon, Texas, and Vermont.

Global Happenings

Data Protection Opinion on Mobile Health

In May 2015, the European Data Protection Supervisor ("EDPS") published an opinion regarding data protection in the age of technological innovation. The opinion aims at drawing attention to the most relevant aspects of data protection for mobile health ("mHealth") that are often, according to the EDPS, overlooked or underestimated. By issuing this opinion, the EDPS hopes to enhance compliance with existing data protection rules and ensure consistent application of such rules. The EDPS makes four key recommendations:

  • In future mHealth policymaking, the EU legislator should foster accountability and allocation of responsibility to those involved in the design, supply, and functioning of apps (including designers and device manufacturers);
  • App designers and publishers should design devices and apps to increase transparency and information in relation to data processing and avoid collecting more data than necessary to perform the expected function by embedding privacy and data protection settings in the design;
  • Industry should utilize "Big Data" in mHealth to benefit app users, as opposed to using it for potentially harmful practices such as discriminatory profiling; and
  • The EU legislator should enhance data security and encourage both the application of privacy by design and the development of building blocks and tools.

Finally, the EDPS explains that because the sector is still largely unregulated, data protection principles and guidance are needed to increase legal certainty and trust in mHealth, and such guidance will contribute to the full development of the mHealth sector.

Health Care Sector Comes Out on Top in Data Protection Eurobarometer Survey

On June 24, 2015, the European Commission published the results of its Data Protection Eurobarometer survey, which was conducted in March 2015. During the course of the survey, almost 28,000 face-to-face interviews were carried out across the European Union with the aim of studying the perceptions of EU citizens on data protection. Although the results show public trust in digital environments remains low, with two-thirds of respondents expressing concern about a lack of control over online information, the health care sector is the most trusted of any sector. Nearly three-quarters of respondents said that they trusted hospitals and medical institutions to protect their personal data, although this figure has declined by 4 percent since the 2010 survey. In contrast, six out of 10 respondents say they do not trust phone companies and internet service providers. The results of the survey will be used to finalize the EU data protection reform.

European Code Related to Privacy and Security in mHealth

The European Commission recently announced plans for a Europe-wide, industry-led Code of Conduct for privacy and security in the mHealth sector. The objective of the Code is to foster citizens' trust in mHealth apps and raise awareness of and facilitate compliance with European data protection rules for app developers. The Code is part of a number of ongoing initiatives from the European Commission in mHealth following a recent industry-wide consultation. Cristiana Spontoni and Indradeep Bhattacharya recently participated in a Q&A with the journal E-health Law and Policy, discussing the Code and what it could mean for the mHealth sector across Europe.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Kevin D. Lyles
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Emails

From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.